SCI Pharmtech, Inc. (TWSE: 4119)
Health Care · Pharmaceuticals · TW
NT$54.40
-2.16% today · -7.6% 1Y
SCI Pharmtech, Inc. (TWSE: 4119) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $203.32M and employs 202 people.
Over the last twelve months the share price has lost 7.6%, trading between 39.60 and 60.70.
Tweenvest scores SCI Pharmtech, Inc. across four factors: quality 60/100, value 48/100, growth 8/100, dividend 39/100. Its strongest factor is quality.
4119 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $203.32M
- Revenue (TTM)
- $39.62M
- P/E
- 108.71
- EPS
- 0.50
- Dividend yield
- 1.38%
- Beta (5Y)
- -0.00
- 52-week high
- NT$60.70
- 52-week low
- NT$39.60
- Avg volume (3M)
- —
- Shares outstanding
- 119.51M
- Employees
- 202
- Next earnings
- —
About SCI Pharmtech, Inc.
SCI Pharmtech, Inc., founded in 1987 and based in Taoyuan City, Taiwan, specializes in the comprehensive lifecycle of pharmaceutical components. The company's core operations involve the research and development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs), chemical intermediates, and specialty chemicals. Its extensive portfolio of APIs includes critical compounds such as Articaine HCl, Atomoxetine HCl, Bisoprolol Fumarate, Brinzolamide, Cannabidiol, and Dexmethylphenidate HCl, among many others. Additionally, SCI Pharmtech produces a wide array of intermediate products, featuring substances like Azetidin-3-ol hydrogenchloride, Diethyl Isobutyl Malonate, Pyrogallolaldehyde, and various specialized esters and alcohols, which serve as essential building blocks in chemical synthesis. Beyond its standard product lines, the company also offers custom manufacturing services tailored to specific client needs. SCI Pharmtech maintains a robust international presence, distributing its products to significant markets across the globe, including Italy, China, the United States, Germany, Taiwan, Switzerland, Spain, Japan, and the Netherlands.
- ISIN
- TW0004119003
- Founded
- 1987
- Listed since
- Jan 7, 2004
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)CASE: RMDA | $210.00M | EGP5.41 | -0.73% |
| Huons Global Co., Ltd.KOSDAQ: A084110 | $209.76M | ₩23,100.00 | +2.44% |
| Sinphar Pharmaceutical Co.,Ltd.TWSE: 1734 | $204.29M | NT$32.40 | +0.93% |
| Beta Drugs LimitedNSEI: BETA | $204.27M | Rs1,950.20 | -5.94% |
| Humedix Co., Ltd.KOSDAQ: A200670 | $196.90M | ₩25,650.00 | -0.19% |
| Seikagaku CorporationTSE: 4548 | $195.53M | ¥567.00 | -0.70% |
| Newron Pharmaceuticals S.p.A.SWX: NWRN | $194.03M | CHF7.59 | -6.53% |
| Ha Tay Pharmaceutical JSCHNX: DHT | $193.22M | ₫50,200.00 | 0.00% |
Figures last refreshed Oct 11, 2026.